Effect of platelet concentration on clinical improvement in treatment of early stage-knee osteoarthritis with platelet-rich plasma concentrations
Osteoarthritis (OA) of the knee is a progressive disease involving the intra-articular (IA) tibiofemoral and patellofemoral cartilage1). Conservative treatment modalities are the first choice in younger and middle-aged populations with cartilage damage and OA of the knee.PRP in Knee OA June 2017
The temporal effect of platelet-rich plasma on pain and physical function in the treatment of knee osteoarthritis: systematic review and meta-analysis of randomized controlled trials
Osteoarthritis (OA) is a major cause of knee disability involving cartilage damage related to an inadequate healing response in the inflammatory milieu. Current
non-surgical treatment modalities include physiotherapy, analgesia, non-steroidal anti-inflammatory drugs, and intra-articular injections, such as hyaluronic acid (HA), corticosteroids, or Ozone, with the purpose of reducing symptoms and improving joint function.
Platelet‑rich plasma shows beneficial effects for patients with knee osteoarthritis by suppressing inflammatory factors
Knee osteoarthritis is a degenerative disease that may develop due ageing, obesity, strain, congenital abnormal joints, joint deformity or trauma. It is caused by many factors, such as degradation of articular cartilage injury, joint edge and subchondral bone hyperplasia of reactivity.PRP in Knee Osteoarthritis Mar 2017
Intra-articular injections of platelet-rich plasma (PRP) to treat symptoms of knee osteoarthritis (OA) have been successfully used in young patients and in the early stages of disease. No previous studies have analyzed outcomes of PRP injections during the late stages.PRP in Advanced Osteoarthritis